BCL2L11 and acute lymphoblastic leukemia: Taken together, our data show that inhibition of the MEK/ERK pathway by SEL, which prevents phosphorylation and inhibition of the pro-apoptotic protein BIM, is critical to the synergistic effect observed in pevonedistat + SEL treated ALL cells.